For this phase @ , single-center , double-blind , parallel , placebo-controlled trial ( ClinicalTrials.gov identifier NCT@ ) , @ patients who had MJD/SCA@ with a disease duration @ years and an independent gait were randomly assigned ( @:@ ) to receive either lithium or placebo .